期刊文献+

应用小剂量糖皮质激素治疗儿童支原体肺炎的临床研究 被引量:1

原文传递
导出
摘要 目的观察小剂量糖皮质激素辅助治疗胸部X线呈大片状影的小儿肺炎支原体肺炎的疗效。方法将肺炎支原体肺炎胸部X线表现为大片状影患JL64例随机分为2组,均给予常规治疗。治疗组此基础上给予地塞米松注射No.25mg/(kg·d)或甲强龙注射剂2mg/(kg·d)静脉滴注,连用3~5d。对比观察两组退热、咳嗽、肺部体征及胸部X线大片阴影消退时间、C反应蛋白变化及住院时间。结果治疗组发热持续时间、肺炎症状改善、胸部X线大片影消退时间及住院时间均明显短于对照组,差异有统计学意义(P〈0.05),且C反应蛋白水平随病情好转显著下降,差异有统计学意义(P〈0.05)。结论早期应用小剂量激素辅助治疗胸部X线呈大片影小儿肺炎支原体肺炎,可有效缓解临床症状,缩短发热和肺部大片影消退时间,减少住院天数,疗效确切。
出处 《中国实用乡村医生杂志》 2011年第9期53-54,共2页 Chinese Practical Journal of Rural Doctor
  • 相关文献

参考文献8

  • 1陆权,陆敏.肺炎支原体感染的流行病学[J].实用儿科临床杂志,2007,22(4):241-243. 被引量:316
  • 2刘洋,李敏,徐佩茹.肺炎支原体肺炎发病机制研究进展[J].临床儿科杂志,2011,29(2):196-198. 被引量:138
  • 3Jaye DL, Waites KB. Clinical applications of C-reactive pretein in pediatric [J]. Pediatr Infect Dis J, 1997, 16(8): 735.
  • 4朴桂花,丁晓燕,丁旭.C-反应蛋白在儿童肺炎支原体感染中临床价值的探讨[J].中国妇幼保健,2006,21(14):1973-1974. 被引量:8
  • 5Lee KY, Lee HS, Hong JH, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children [J]. Pediatr Pulmonol, 2006, 41(3): 263-268.
  • 6Tamura A, Matsubara K, Tanaka T, et al. Methyloredrtisolone pulse therapy for refractory. Myeoplasma pneumoniae pneumonia in children [J]. J Infect, 2008, 57(3): 223-228.
  • 7Tsurtar, Kawamura Y, Moue T, et al. Cortico-steroid therapy for hemolytic anemia and respiratory failure due to Mycoplasma pneumoniae [J]. Intern Med, 2002, 41(3): 229-232.
  • 8Wachowskio, Demirakcas, Mullerk M, et al. Mycoplasma pneumoniae associated organizing pneumonia in a 10-year old boy [J]. Arch Dis Child, 2003, 88(3): 270-272.

二级参考文献43

  • 1庞保东,董琰,张慧玉,曹丽华,刘寅,吴家骅.儿童社区获得性肺炎非典型病原体临床分析[J].中国综合临床,2005,21(9):849-850. 被引量:21
  • 2Waites KB,Talkington DF.Mycoplasma pneumoniae and its role as a human pathogen[J].Clin Mierobiol Rev,2004,17(4):697-728.
  • 3Chaudhry R,Varahney AK,Malhotra P.Adhesion proteins of Mycoplas ma pneumoniae[J].Front Biosci,2007,12:690-699.
  • 4Yavlovich A,Tarshis M,Rottem S.Internalization and intracellular survival of Mycoplasma pneumoniae by non-phagocytic cells[J].FEMS Microbiol Lett,2004,233(2):241-246.
  • 5Kannan TR,Provenzano D,Wright JR,et al.Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae[J].Infect Immun,2005,73 (5):2828-2834.
  • 6Kannan TR,Baseman JR.ADP-ribosylating and vacuolating eytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens[J].Proc Nail Acad Sci USA,2006,103 (17):6724-6729.
  • 7Kunnan TR,Provenzano D,Wright JR,et al.Identification and characterization of human surfactant protein A binging protein of Mycoplasma pneumoniae[J].Infect Immun,2005,73(5):2828-2834.
  • 8Shimizu T,Kida Y,Kuwano K.A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-kappa B through TLR1,TLR2 and TLR6[J].J Immunol,2005,175(7):4641-4646.
  • 9Into T,Kiura K,Yasuda M.et al.Stimulation of human Tolllike receptor (TLR)2 and TLR6 with membrane lipoproteins of Mycoplasma fementans induces apoptotic cell death after NFkappa B activation[J].Cell Microbiol,2004.6(2):187-199.
  • 10Stelmach I,Podsiodlowicz-Borzeka M,Grzelewski T,et al.Humoral and cellular immunity in children with Mycoplasma pneumoniae infection:a 1-year prospective study[J].Clin Diagn Lab Immunol,2005,12(10):1246-1250.

共引文献451

同被引文献6

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部